inTRAvent Medical Partners LP, founded in 2015, is a privately held medical device company dedicated to bringing intra-operative imaging and navigation to the bedside to improve neurosurgical procedures.
The company’s first product, the FDA-cleared SOLOPASS® system for aiding in the frontal placement of intra-ventricular catheters, is designed to provide imaging and guidance to improve one of the most common and lifesaving procedures in neurointensive care. Conceptualized at Penn State Hershey Medical Center by Dr. Sprague W. Hazard III, M.D., SOLOPASS® allows caregivers to visualize the ventricular system, deep within the brain, to enable precision planning and guidance.
